John Leaman | CFO |
Adrian Adams | Chairman & CEO |
Leonard Paolillo | Chief Commercial Officer |
Ken Cacciatore | Cowen and Company |
Laura Chico | Wedbush Securities |
Eddie Hickman | Guggenheim Securities |
Good morning, ladies and gentlemen, and Welcome to Impel NeuroPharma’s Fourth Quarter and Full-Year 2021 Earnings and Corporate Update Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to Impel’s Chief Financial and Business Officer, John Leaman.
Thank you, Norma and good morning, everyone.
We are delighted that you could join us today for Impel NeuroPharma’s quarterly earnings conference call, during which we will review our fourth quarter and full-year 2021 financial results, as well as providing a general corporate update.